ArticleFrontiers in immunology2024

Improving cancer immunotherapy in prostate cancer by modulating T cell function through targeting the galectin-1.

Hsiao-Chi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.